Returning People to Work and Productivity

For more than 30 years, our three fully integrated divisions have provided clinical evaluation and screening services to employers, payers and government agencies, as well as clinical research services to pharmaceutical sponsors and CROs.


Our Government Services Division supports local, state, and federal agencies and delivers professional and objective evaluations. We provide medical and psychological examinations as well as ancillary services. IMA operates a full-service Operations Center, including scheduling assistance.


Our Payer Services Division includes behavioral health, physical medicine specialty services and expert medical care coordination. We work with a wide range of organizations within the workers’ compensation, disability, liability and auto markets. Our Payer Services meet the evaluation, screening and case management needs of Carriers, TPAs, Public Entities and Employers.


The Clinical Research Division performs all types of Phase II-IV clinical trials in multiple therapeutic areas through a flexible nationwide network of site locations and virtual capabilities. IMA also has a robust and expanding patient database of potential study participants. 

Through tech-enabled services from The IMA Group…


Improve the quality of your evaluations through our national network of top-performing providers

Reduce your risks of hiring and staffing through superior screening and evaluation services

Engage constituents and achieve higher satisfaction levels with screening and evaluation services that respect their time and needs

Gain value from leading-edge technology that will deliver better, faster and more efficient outcomes

Experience exceptional customer service that results in better outcomes and faster turn-around times

Uncover new ways to reduce and manage costs without compromising quality or satisfaction

Collaborate with a technology-driven company dedicated to utilizing predictive analytics and other industry breakthroughs to deliver solutions

Develop innovative and meaningful treatments based on our Phase II-IV Clinical Trials